Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose human albumin for neuroprotection in acute ischemic stroke
NCT00235495Phase 3Terminated
- Sponsor
- University of Miami
- Start
- Jun 2006
- Primary completion
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of albumin (human) in ischemic stroke, sponsored by University of Miami. Started Jun 2006; status: terminated.
02
Drugs
albumin (human)
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00235495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235495.